Stocks and Investing Stocks and Investing
Thu, December 16, 2021

Matthew Harrison Initiated (BNTX) at Hold and Held Target at $294 on, Dec 16th, 2021


Published on 2024-10-27 19:00:31 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Initiated "BioNTech SE" (BNTX) at Hold and Held Target at $294 on, Dec 16th, 2021.

Matthew has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 4 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $225 on, Tuesday, November 9th, 2021
  • Akash Tewari of "Jefferies" Initiated at Hold and Held Target at $230 on, Thursday, October 7th, 2021
  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021
  • Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Robert Burns of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $360 on, Wednesday, November 10th, 2021
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
Contributing Sources